Op-ed: An open letter to the Food and Drug Administration Commissioner
The U.S. Food and Drug Administration (FDA) is going through a major reorganization to improve efficiency and protect public health. A recent hearing in front of the House Committee on Oversight and Accountability concluded that the agency stumbles from …